38,135 Shares in SPDR S&P China ETF (NYSEARCA:GXC) Purchased by Banco Santander S.A.

Banco Santander S.A. bought a new position in shares of SPDR S&P China ETF (NYSEARCA:GXC) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 38,135 shares of the company’s stock, valued at approximately $3,132,000. Banco Santander S.A. owned approximately 0.57% of SPDR S&P China ETF at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Osborne Partners Capital Management LLC lifted its position in shares of SPDR S&P China ETF by 3.0% in the 3rd quarter. Osborne Partners Capital Management LLC now owns 192,829 shares of the company’s stock worth $15,835,000 after purchasing an additional 5,564 shares during the period. Jane Street Group LLC boosted its position in SPDR S&P China ETF by 327.5% during the 1st quarter. Jane Street Group LLC now owns 190,015 shares of the company’s stock valued at $12,499,000 after acquiring an additional 145,562 shares in the last quarter. swisspartners Advisors Ltd increased its holdings in shares of SPDR S&P China ETF by 1.8% in the 3rd quarter. swisspartners Advisors Ltd now owns 132,307 shares of the company’s stock valued at $10,865,000 after acquiring an additional 2,360 shares during the period. Bordeaux Wealth Advisors LLC bought a new position in shares of SPDR S&P China ETF in the 2nd quarter worth $3,119,000. Finally, Flow Traders U.S. LLC purchased a new stake in shares of SPDR S&P China ETF during the 1st quarter worth $2,858,000.

SPDR S&P China ETF Price Performance

Shares of GXC stock opened at $77.56 on Friday. The stock’s 50-day moving average is $79.01 and its 200 day moving average is $72.94. SPDR S&P China ETF has a 1-year low of $59.45 and a 1-year high of $97.17. The company has a market cap of $515.77 million, a P/E ratio of 9.52 and a beta of 0.84.

SPDR S&P China ETF Company Profile

SPDR S&P China ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI China Index (the Index). The Index is a market capitalization-weighted index that defines and measures the investable universe of publicly traded companies domiciled in China, but legally available to foreign investors.